P01. Direct acting antiviral therapy of chronic hepatitis C in Denmark: treatment response, virologic failure and resistance associated substitutions
Christina Sølund, Sofie Hallager, Henrik B. Krarup, Birgit T. Røge, Peer B. Christensen, Alex L. Laursen, Jan Gerstoft, Jens Bukh, Nina Weis, The DANHEP group

P02. Hepatitis e virus epidemiology among HIV infected women in an urban area in Tanzania
Ebba Mannheimer, Lene Holm Harritshøj, Zahra Persson Theilgaard, Mercy Chiduo, Sofie Midgley, Jan Gerstoft, Henrik Ullum, Terese L. Katzenstein

P03. Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children
Sandra Soeria-Atmadja, Emma Österberg, Lars L Gustafsson, Marja-Liisa Dahl, Jaran Eriksen, Johanna Rubin and Lars Navér

P04. Effect of dolutegravir in combination with NRTI in HIV-1 infected individuals with pre-existing NRTI-mutations
Erik Sörstedt, Christina Carlander, Leo Flamholc, Bo Hejdeman, Veronica Svedhem-Johansson, Anders Sönnerborg, Magnus Gisslén, Aylin Yilmaz

P05. Subtype-Specific Dolutegravir Inhibition in Treatment naïve HIV-1 Integrase
Kamalendra Singh, Ujjwal Neogi, Leonard C Rogers, Shambhu G. Aralaguppe, Seongmi Kim, Stefan Sarafianos, Anders Sönnerborg

P06. Phenotypic co-receptor tropism and Maraviroc sensitivity in HIV-1 subtype C
Abu Bakar Siddik, Alexandra Haas, Wondwossen Amogne, Soham Gupta, Joelle Bader, Thomas Klimkait, Anders Sönnerborg, Ujjwal Neogi

P07. Decreasing Prevalence of Transmitted Drug Resistance among ART-naïve, HIV-1-infected Patients in Iceland, 1996-2012
Malik Sallam, Gülşen Özkaya Şahin, Hlynur Indriðason, Joakim Esbjörnsson, Arthur Löve, Anders Widell, Magnus Gottfreðsson and Patrik Medstrand

P08. HIV-induced modifications of TIGIT expression impair CD8 T cell polyfunctionality
Lydia Scharf, Johanna Tauriainen, Michael R Betts, Marcus Buggert, Annika C Karlsson

P09. Multiplexed next-generation sequencing and de novo assembly to obtain near full-length HIV-1 genome from plasma virus
Shambhu G. Aralaguppe, Abu Bakar Siddik, Ashokkumar Manickam, Wondwossen Amogne, Luke Elizabeth Hanna, Anders Sonnerborg, Ujjwal Neogi

P10. A Longitudinal Study on the Dynamics of Plasma Neutralising Antibodies and Determinants in HIV-2 Infection
Hans Norrgren, Gülşen Özkaya Şahin, Sara Karlson, Antonio Biague, Fredrik Månsson, Marianne Jansson and Sweden-Guinea-Bissau Cohort Research Group

P11. Changes in platelet aggregation and coagulation in HIV-1 patients switching to or from abacavir: Tenofovir Abacavir Platelet Activation Study (TAPAS)
Frederikke Falkencrone Rönsholt, Marie Helleberg, Pär Ingemar Johansson, Judith Haismann, Sisse Rye Ostrowski, Jan Gerstoft

P12. CNS immune activation still present despite > 10 years of effective antiretroviral therapy of HIV-1
Gustaf Hammarlund, Åsa Mellgren, Dietmar Fuchs, Henrik Zetterberg, Lars Hagberg, Staffan Nilsson, Aylin Yilmaz, Arvid Edén, Magnus Gisslén

P13. Differences in microbiota and inflammation in a cohort of elite controllers
Piotr Nowak, Jan Vesterbacka, Javier Rivera, Marc Noguera-Julian, Kajsa Noyan, Roger Paredes, Anders Sönnerborg

P14. HIV-1 Elite Controllers maintain low frequency of CD4+ T cells expressing inhibitory markers associated with T cell exhaustion
Kajsa Noyan, Mike R Betts, Jan Vesterbacka, Marcus Buggert, Anders Sönnerborg

P15. The Framingham score – a useful predictor of death (of all causes) in HIV-patients above 50 years of age on effective antiretroviral treatment (ART)
Göran A Bratt, Cina Missalidis, Julia Ekblom and Anders Blaxhult

P16. Prevalence of osteoporosis in people living with Human Immunodeficiency Virus in a large outpatient clinic in Copenhagen, Denmark
Maria Wessman, Kristina Thorsteinsson, Anne-Mette Lebech, An-Brit Eg Hansen, Terese L. Katzenstein, Nina Weis

P17. Drug retention time; a real life Swedish nationwide cohort study on InfCareHIV 2009-2014
Amanda Häggblom, Stefan Lindbäck, Magnus Gisslen, Leo Flamholc, Bo Hejdeman, Andreas Palmborg, Amy Leval, Eva Herweijer, Sverrir Valgardsson, Veronika Svedhem

P18. Treatment outcome for HIV-1 infected patients in Sweden on Eviplera
Amanda Häggblom, Catharina Maijgren Steffensson, Veronica Svedhem Johansson, Göran Skoglund

P19. Antibody profiling of HIV-1 proteomes signifies decreasing antibody profile during long term antiretroviral therapy
Mohammed M. Morshed, Wang Zhang, Kajsa Noyan, Jan Vesterbacka, Anders Sönnerborg, Ujjwal Neogi

P20. Optimization of HIV-1 latency-reversing agents (LRAs) combinations to improve HIV latency reactivation
Wang Zhang, Anders Sönnerborg, Aman Russom, Ujjwal Neogi

P21. Subtype-independent broad inhibitory activity of EFdA with or without drug resistance mutations in HIV-1 reverse transcriptase
Duncan T. Njenda, Md Shanawazur Rahman, Kamalendra Singh, Stefan Sarafianos, Anders Sonnerborg, Ujjwal Neogi

P22. Construct, design and immunogenicity of a minicircle DNA vector encoding a short HIV peptide
Sofia Stenler, Lena Hansen, Jorma Hinkula, Stefan Petkov, Karl Ljungberg, Karin E Lundin, Pontus Blomberg, Britta Wahren

P23. Assessing HIV related knowledge in an immigrant population-based survey
Paula J Tiittala, Pia S Kivelä, Matti A Ristola, Kirsi Liitsola

P24. A high rate of HIV-1 acquisition post immigration among migrants in Sweden determined by a CD4+ T-cell decline trajectory model
Gaetano Marrone, Johanna Brännström, Veronica Svedhem, Ujjwal Neogi, Anders Sönnerborg

P25. Baseline predictors of treatment outcome in a multicenter prospective clinical cohort: a study from a resource-limited setting
Nigus F. Telele, Amare W. Kalu, Gaetano Marrone, Solomon GebreSelasie, Daniel Fekade, Belete Tegbaru, Anders Sönnerborg

P26. Monophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses – an analysis of a prospective country-wide cohort
Amare W. Kalu, Nigus F Telele, Solomon Gebreselasie, Daniel Fekade, Samir Abdurahman, Gaetano Marrone, Anders Sönnerborg

P27. Engagement of community leaders in improving male involvement in prevention of mother-to-child transmission of HIV services in Dar es Salaam, Tanzania
Goodluck Lyatuu, Sarah Mdingi, Happiness Koda, Yusuph Chende, Martha Tsere, Helen Siril, Irene Andrew, Aisa Mhalu, Tabu Mganga, Happy Magatti, Noela Chacha, Helga Naburi, Eric Aris, Aisa Muya, Gunnel Biberfeld, Charles Kilewo, Anna Mia Ekström

P28. Results of a Community-level Anti-HIV/AIDS Stigma and Homophobia Intervention in New York City: Project CHHANGE
Victoria Frye, Mark Q. Paige, Steven Gordon, David Matthews, Emily Greene, Phil Smith, Jo C. Phelan, Beryl A. Koblin, and Vaughn Taylor-Akutagawa
Withdraw

P29. Mode of delivery among HIV-infected women in Helsinki University Hospital 2006-2013
Inka Aho, Marja Kaijomaa, Pia Kivelä, Jussi Sutinen, Oskari Heikinheimo

P30. Epidemiology and outcome of HIV-patients co-infected with tuberculosis in Finland
Ville Holmberg, Hanna Soini, Pia Kivelä, Matti Ristola

P31. Sexual behaviors reported by a sample of HIV-positive men who have sex with men: A descriptive study in Khon Kaen, Thailand
Jiratha Budkaew